Latest News

2023.09.06
Leadgene Biomedical Wins 2023 Taipei Biotech Awards - Innovation Award Special Mention Awards
We're excited to announce that Leadgene Biomedical has won the 2023 Taipei Biotech Awards - Innovation Award Special Mention Awards. This prestigious accolade highlights our team's dedication to advancing biotechnology through innovative research. Thank you to the Taipei City Hall and Taipei Biotech Awards committee for this honor!
2023.08.11
Leadgene Biomedical Achieves Milestone Recognition, Paving the Way for Advanced Kidney Disease Diagnostics in Taiwan
Leadgene Biomedical has secured approval from the Industrial Development Bureau of the Ministry of Economic Affairs. This approval underscores the company's commitment to research and the manufacturing of the “Indoxyl Sulfate (IS) ELISA Kit.” As a result, Leadgene has garnered recognition as a leading biotech and pharmaceutical company, setting the stage for potential investment deductions and tax benefits in the future.
2023.07.24
Leadgene Biomedical, Inc. Aims for IPO within Three Years Driven by Reagent Raw Materials and Uremic Toxin Detection Kit
Relying on its immunoassay technology platform, Leadgene employs a CRDMO (Contract Research Development Manufacturing Organization) model, providing comprehensive, customized services. Looking ahead, Chairman Chuang Yung-Chun aims to achieve an initial public offering (IPO) within the next three years.
1
/
3
2023.04.27

Indoxyl Sulfate Antibody Secures Second U.S. Patent
2023.03.13

Leadgene Indoxyl Sulfate ELISA Kit Helps Medical Institutions Seize the Golden Treatment Period for Kidney Disease
2022.11.10

31st National Award of Outstanding SMEs Awarded!
2023.03.14

New Distributor Announcement - AS ONE Corporation
2023.02.24

President Tsai meets the winners of the 2022 Taiwan BIO Awards
2023.02.20

Exclusive Distribution Partnership - Kim & Friends, Inc.
2022.12.27

New Distributor Announcement - Biozol Diagnostica Vertrieb GmbH
2022.12.09

(CE-IVD) LEADGENE® Indoxyl Sulfate ELISA Kit: Rapid Detection and Surveillance of Chronic Kidney Disease
2022.12.07

New Partnership Announcement - Caltag Medsystem
2022.09.07

Press Release: Leadgene Utilizes LEADSPHERE™ Lyophilization Technology to Make Reagents Stable for Long-Term Logistics
2022.07.28

Achieved 2022 Taiwan BIO Awards - Emerging Company of the Year!
2022.06.13

Leadgene Biomedical and CYTENA BPS will cooperate and fuel Taiwan’s protein drug production